Invest in OpenAI: 5 Pathways for 2025
OpenAI isn't public yet. Discover 5 legitimate ways to invest: Microsoft, NVIDIA, AI ETFs, pre-IPO shares, or wait for IPO.
Last Updated: June 2025
This article is for informational purposes only and does not constitute financial, investment, or legal advice. Consult a qualified financial advisor before making investment decisions.
OpenAI is not publicly traded, and there is no OpenAI stock ticker on the NYSE or NASDAQ. There are, however, five legitimate ways to gain financial exposure to the company right now, and this guide walks through each one in detail.
If you've been using ChatGPT and watching OpenAI dominate the AI conversation for the past two years, your instinct to look for an investment pathway is shared by millions of other retail investors. The question isn't whether the interest is valid. The question is which pathway fits your situation.
Important: As of June 2025, OpenAI does not have a publicly traded stock. There is no OpenAI stock ticker or stock symbol on the NYSE, NASDAQ, or any other public exchange. OpenAI is a private company.
Key Takeaways
- OpenAI is a private company with no publicly traded stock and no stock ticker as of June 2025
- Five investment pathways exist: buying Microsoft (MSFT), buying NVIDIA (NVDA), buying AI-focused ETFs, purchasing pre-IPO shares through secondary market platforms, or waiting for a direct IPO
- Secondary market access to OpenAI pre-IPO shares requires accredited investor status under SEC rules
- Microsoft and NVIDIA are accessible to all investors through any standard retail brokerage, as are AI ETFs
- OpenAI's 2025 conversion to a Public Benefit Corporation (PBC) is widely interpreted as a prerequisite step toward a future IPO, though no IPO date has been announced
On This Page
- What Is OpenAI? (And Why Investors Want In)
- Is OpenAI Publicly Traded? Does It Have a Stock Ticker?
- When Will OpenAI Have an IPO?
- How to Invest in OpenAI: Your 5 Pathways
- Understanding OpenAI's Corporate Structure: What Every Investor Should Know
- Risks of Investing in OpenAI (Directly or Indirectly)
- Frequently Asked Questions About Investing in OpenAI
- Final Thoughts: Getting OpenAI Exposure in 2025
- Financial Disclaimer
What Is OpenAI? (And Why Investors Want In)
OpenAI was founded in 2015 as a nonprofit AI research lab and has grown into one of the most closely watched private companies in the world, raising $6.6 billion in September 2024 at a valuation of approximately $157 billion, according to reporting from Bloomberg and Reuters.
Sam Altman serves as CEO. A former president of Y Combinator and one of OpenAI's co-founders, Altman is the central figure shaping the company's strategic direction, fundraising decisions, and corporate restructuring. His choices on corporate structure and potential IPO timing directly affect which investment pathways will become available, and when.
The case investors are making is grounded in the scale of OpenAI's product adoption. ChatGPT became the fastest-growing consumer application in history, and OpenAI's current product lineup spans GPT-4o, DALL-E 3, Sora (video generation), and Codex (developer tools). Generative AI, the specific category where OpenAI leads, refers to AI systems capable of producing text, images, code, and other media from natural language input. Goldman Sachs and McKinsey have both published analyses projecting generative AI as a multi-trillion dollar market transformation over the next decade. OpenAI currently holds the strongest brand position in that space by product awareness and commercial adoption.
The company's ownership is institutional and private. Microsoft has invested approximately $13 billion across multiple funding rounds, making it OpenAI's largest external investor. Thrive Capital led the September 2024 round at that $157 billion valuation. SoftBank Group has also made a significant investment commitment. These are venture capital and institutional rounds, meaning they are not accessible to retail investors through standard brokerage accounts.
OpenAI's revenue run rate was estimated at $3.4 billion or more for 2024, according to reporting from The Wall Street Journal and Bloomberg. Projections cited by those same outlets suggest $11.6 billion for 2025, though these are estimates, not confirmed figures. Elon Musk was a co-founder of OpenAI but departed from its board in 2018 and has since founded a competing AI company called xAI, which is a separate private company entirely.
The primary competitors in the generative AI space are Google DeepMind (Gemini models, backed by Alphabet), Anthropic (Claude models, backed by Amazon and Google), Meta AI (Llama open-source models), and xAI (Grok). All are well-funded and actively developing competitive products.
OpenAI's Corporate Structure: From Nonprofit to Capped-Profit to PBC
OpenAI has operated under three distinct corporate structures since its founding: a nonprofit in 2015, a capped-profit LLC beginning in 2019, and a Delaware Public Benefit Corporation (PBC) announced in 2025.
The capped-profit structure that governed OpenAI from 2019 onward was unusual by any corporate standard. Think of it like a business with a written contract that limits how much investors can earn: returns were capped at a multiple of invested capital, somewhere in the range of 100 times, with anything above that ceiling reverting to the nonprofit parent rather than to the investors. This structure aligned profit incentives with OpenAI's stated mission of developing AI for broad human benefit, not purely for shareholder returns.
In 2025, OpenAI announced plans to convert to a Delaware Public Benefit Corporation. A PBC is a standard for-profit corporate structure that codifies a public mission alongside profit generation but does not restrict investor returns the way the capped-profit model did. This distinction matters: a PBC is not the same as a B Corp certification, which is a private certification from B Lab with no legal standing in corporate governance. OpenAI's conversion is a legal restructuring that removes the return caps that previously defined the investment profile.
For investors monitoring OpenAI, this conversion is the most significant recent development. Standard for-profit structures are generally required before a company can conduct an IPO. The 2025 restructuring is widely interpreted as a prerequisite step toward an eventual public offering, though it does not confirm or commit to any timeline.
Is OpenAI Publicly Traded? Does It Have a Stock Ticker?
OpenAI is not publicly traded. As of this article's publication, there is no OpenAI stock ticker or stock symbol listed on the NYSE, NASDAQ, or any other public exchange.
Those two facts answer the three most common questions arriving at this article: there is no OpenAI stock to buy on an exchange, there is no ticker, and there is no stock symbol. The $157 billion figure referenced in press coverage is a private company valuation set during a funding round negotiation, not a live market price. You cannot look up an OpenAI share price on any financial data platform the way you can for a public company.
OpenAI has remained private by choice. Private status lets the company avoid the quarterly earnings pressure and public disclosure requirements of public markets, maintain strategic flexibility, and focus on longer-term research without the short-term obligations that come with public shareholders. Think of it this way: buying a public stock is like buying produce at a grocery store with set prices and open access. Buying into a private company is more like buying part of a local restaurant, which requires a direct deal with the owner and cannot be done through any standard market.
If you're asking specifically whether you can buy OpenAI on Robinhood: no. Robinhood, Fidelity, Schwab, and every other standard retail brokerage platform only list publicly traded securities. Since OpenAI has not conducted an IPO and has no exchange listing, none of these platforms can offer its shares. Retail investors who do not qualify as accredited investors cannot directly purchase OpenAI equity in any form.
The pathway forward for most retail investors runs through publicly traded proxies and AI-focused ETFs, which are covered in the investment options section below.
When Will OpenAI Have an IPO?
As of this article's publication date in June 2025, OpenAI has not announced a firm IPO date and has not filed an S-1 registration statement with the SEC.
An IPO, or Initial Public Offering, is the process by which a private company sells shares to the public for the first time on a regulated exchange. Before conducting an IPO, a company must file an S-1 (the SEC registration document that discloses financial details to prospective investors) and receive SEC review and approval. As of June 2025, no such filing exists for OpenAI in the SEC EDGAR S-1 filing database.
The 2025 PBC restructuring is the most credible forward signal for a potential IPO. Standard for-profit corporate structures are generally required for public offerings. By converting to a PBC, OpenAI removed a structural barrier that made IPO execution difficult under the prior capped-profit model. Many analysts interpret this conversion as a deliberate step in IPO preparation, though OpenAI has not confirmed this publicly.
For context on what a major technology company's public offering looks like: Google went public in August 2004, and Facebook followed in May 2012. Both experiences involved significant pre-IPO anticipation, IPO-day volatility, and post-IPO price discovery that played out over months. These examples are historical context only and do not predict what an OpenAI IPO would look like.
For a historical perspective on how a major semiconductor company navigated its own public offering, when NVIDIA went public and its IPO history provides useful context on the mechanics and timing of technology company IPOs.
For investors who want to prepare for a potential OpenAI IPO, practical steps include:
- Ensure you have a funded brokerage account at a major platform before any IPO announcement
- Monitor the SEC EDGAR S-1 filing database for any OpenAI registration statement, which would be the definitive signal that a public offering is being prepared
- Watch for official OpenAI announcements through their newsroom at openai.com
- Consider your position on IPO-day pricing versus waiting for post-IPO price discovery, since IPO-day prices often reflect significant demand premiums
If waiting for an OpenAI IPO is your strategy, the options in the next section give you something to do in the meantime.
How to Invest in OpenAI: Your 5 Pathways
You have five pathways for gaining financial exposure to OpenAI, each suited to a different investor profile, risk tolerance, and level of access.
The pathways are: (1) buy Microsoft stock as a publicly traded OpenAI proxy, (2) buy NVIDIA stock as an AI infrastructure play, (3) buy AI-focused ETFs for diversified sector exposure, (4) purchase OpenAI pre-IPO shares through secondary market platforms if you qualify as an accredited investor, and (5) wait for a direct IPO. Pathway 5 is covered in the previous section; this section covers the first four in depth.
| Investment Pathway | Investor Type Required | Minimum Investment | Accessibility | Risk Level | OpenAI Exposure Type |
|---|---|---|---|---|---|
| Buy Microsoft (MSFT) | All investors | Share price (verify current price) | Any retail brokerage | Moderate | Indirect proxy; $13B investment, Azure, Copilot |
| Buy NVIDIA (NVDA) | All investors | Share price (verify current price) | Any retail brokerage | Moderate-High | AI infrastructure; not an OpenAI investor |
| Buy AI ETFs (BOTZ, AIQ, ARKQ) | All investors | Share price per ETF (verify) | Any retail brokerage | Moderate | Diversified AI sector; no direct OpenAI shares |
| Secondary market pre-IPO shares | Accredited investors only | Historically $10,000–$100,000+ (verify current minimums) | Forge Global, EquityZen | High | Direct OpenAI equity (illiquid) |
| Wait for IPO | All investors | Share price at IPO (unknown) | Any retail brokerage at IPO date | Depends on timing | Direct OpenAI equity (if IPO occurs) |
Which pathway is right for you?
- Non-accredited retail investor: Options 1 through 3 are your pathways. MSFT, NVDA, plus AI ETFs are all accessible through your existing brokerage account with no special qualifications required.
- Accredited investor seeking direct exposure: Option 4 is available to you. Secondary market platforms require accredited investor verification before you can purchase pre-IPO shares.
- All investors: Monitor for an OpenAI IPO S-1 filing, which would open direct ownership to everyone.
Option 1: Buy Microsoft Stock (MSFT) — Most Accessible OpenAI Proxy
Microsoft (NASDAQ: MSFT) has invested approximately $13 billion in OpenAI across multiple rounds as of 2024, making it OpenAI's largest external investor and the most closely connected publicly traded company to OpenAI's performance.
The investment relationship runs deeper than a financial stake. OpenAI runs its models on Microsoft Azure cloud infrastructure, creating a deep operational dependency that generates direct revenue for Microsoft's cloud division. OpenAI technology powers Microsoft's Copilot products across Office 365 and Bing, as well as the Azure OpenAI Service, creating direct commercial revenue linkage. When OpenAI releases a new model, Microsoft's products are typically the first to incorporate it at scale.
That said, buying MSFT is not the same as buying OpenAI. Microsoft is a $3 trillion-plus company with business lines spanning cloud computing (Azure), productivity software (Office), gaming (Xbox), professional networking (LinkedIn), and enterprise services. OpenAI represents one significant line of business within a large, diversified corporation. If OpenAI's valuation doubles, Microsoft stock would likely benefit, but not proportionally. Azure cloud growth, Office 365 subscription rates, gaming revenue, and overall technology sector conditions all drive MSFT's stock price independently of OpenAI's trajectory.
MSFT shares are available through any major retail brokerage, including Fidelity, Schwab, Robinhood, E*TRADE, and others. No accredited investor status is required. This is not a recommendation to purchase MSFT; it is a description of the option for your evaluation.
Option 2: Buy NVIDIA Stock (NVDA) — The AI Infrastructure Play
NVIDIA (NASDAQ: NVDA) supplies the specialized GPU chips, primarily the H100 and A100 processors, that power OpenAI's AI model training at scale. Without NVIDIA's chips, OpenAI could not train or run its large language models at the speed and scale required for commercial products.
This makes NVIDIA's relationship to OpenAI a hardware dependency rather than an ownership relationship. NVIDIA is not an investor in OpenAI. Microsoft invested money in OpenAI and holds equity. NVIDIA sells products to OpenAI and benefits from OpenAI's growth as a customer, but holds no OpenAI shares. The distinction matters for how you think about the exposure: buying NVDA gives you exposure to the AI compute infrastructure business, which benefits from all AI model training across every company, not just OpenAI. If Anthropic, Google DeepMind, and Meta AI all expand their model training, NVIDIA benefits from that growth too.
For investors who want to understand the full picture of NVIDIA's business before considering it, NVIDIA's stock overview and business fundamentals covers the company's revenue model, competitive position, and key business segments.
NVDA shares are available through any major retail brokerage. The risk note that applies here is real: NVIDIA trades at high valuation multiples relative to earnings, making it sensitive to any slowdown in AI capital spending. Tracking NVIDIA's earnings dates and reporting calendar can help you monitor the company's financial performance on a quarterly basis.
This is not a recommendation to purchase NVDA. It is an option for your evaluation alongside the other pathways in this article.
Option 3: Buy AI-Focused ETFs — The Diversified Approach
No publicly available ETF currently holds OpenAI shares directly, because OpenAI is a private company and its shares are not available on any public exchange.
Several AI-focused ETFs do hold the major publicly traded companies with meaningful AI sector exposure, including OpenAI partners and competitors. Three specific examples worth researching:
- BOTZ: Global X Robotics & Artificial Intelligence ETF, managed by Global X. Holds a basket of companies involved in AI and robotics, including NVDA and other AI hardware and software names.
- AIQ: Global X Artificial Intelligence & Technology ETF, managed by Global X. Broader AI technology exposure including software and semiconductor companies.
- ARKQ: ARK Autonomous Technology & Robotics ETF, managed by ARK Invest. Focuses on autonomous technology and AI-driven companies, with an active management approach.
These ETFs are presented as illustrative examples, not as product endorsements. The AI ETF space changes frequently. Before investing in any ETF, verify its current holdings directly on the fund company's website (globalxetfs.com for BOTZ and AIQ, ark-funds.com for ARKQ) or through an ETF database like etf.com. None of these funds hold OpenAI shares.
The advantage of ETFs for this use case is accessibility. Any investor, regardless of income or net worth, can buy these funds through Robinhood, Fidelity, Schwab, or any retail brokerage. There is no accredited investor requirement and no minimum investment beyond the share price. ETFs also reduce single-company risk by spreading exposure across many holdings.
The trade-off is dilution. ETFs spread your exposure across dozens of companies, which means strong performance from OpenAI's partners and competitors benefits you partially, not fully. You also pay expense ratios (annual management fees built into the fund), which reduce your net return relative to owning individual stocks directly.
Alphabet (NASDAQ: GOOGL) provides AI sector exposure through OpenAI's primary competitor. Google DeepMind is Alphabet's AI research lab, and Gemini is its competing large language model family. Alphabet also owns dominant search and YouTube platforms, alongside Android, that it is actively integrating with AI capabilities. Buying GOOGL provides AI sector exposure but zero direct OpenAI investment relationship.
Amazon (NASDAQ: AMZN) invested heavily in Anthropic, the company behind the Claude AI models, making it a proxy for Anthropic rather than OpenAI. AMZN's AWS cloud service also competes directly with Azure for AI infrastructure workloads. If you are considering AMZN for AI exposure, understand that it tracks a different AI company than OpenAI.
Option 4: Buy OpenAI Pre-IPO Shares Through Secondary Markets (Accredited Investors Only)
Buying OpenAI pre-IPO shares through secondary market platforms is only available to accredited investors, meaning individuals who meet the SEC's income or net worth threshold for private investment access.
Do You Qualify as an Accredited Investor?
Per SEC Rule 501 of Regulation D, you qualify as an accredited investor if you meet at least one of the following criteria:
- Income test: Annual income exceeding $200,000 as an individual, or $300,000 combined with a spouse or spousal equivalent, for the past two consecutive years, with the expectation of the same in the current year
- Net worth test: Net worth exceeding $1 million, excluding the value of your primary residence
- Professional certification: Holding a valid Series 7, Series 65, or Series 82 license
For the full authoritative definition, see the SEC's accredited investor definition.
If you do not qualify as an accredited investor: The public market options above — MSFT, NVDA, and the ETFs described in Options 1 through 3 — are fully accessible pathways that require no accredited investor status. These are legitimate investment pathways, not fallback options.
What Is the Secondary Market for Private Shares?
The secondary market for private shares refers to platforms that facilitate the buying and selling of equity in private companies between individual parties, outside of any primary fundraising round. This is a distinct concept from the secondary market for publicly traded stocks, where you buy shares of Apple or Google from another trader through your brokerage.
Pre-IPO investing means purchasing equity in a company before it has conducted a public offering. The shares you would be purchasing on these platforms are typically held by OpenAI employees or early investors who have vested their equity and want to sell before any IPO. They sell their shares through a licensed broker-dealer acting as an intermediary. You hold the shares in a custodian account and cannot sell them on any open market. Your exit options are: an OpenAI IPO (at which point shares may convert to publicly tradable stock), an acquisition of OpenAI by another company, or finding another secondary buyer.
Pre-IPO investments are illiquid by definition. You cannot sell them the way you sell a stock. They may have lock-up periods, transfer restrictions, and other conditions. They are also difficult to value accurately, since no daily market price exists.
How to Buy OpenAI Pre-IPO Shares: Step-by-Step
Verify your accredited investor status. Check the income and net worth criteria above. If you do not qualify, stop here and proceed to Options 1, 2, or 3. Platforms will verify your status before allowing you to transact, and purchasing without qualification violates SEC rules.
Choose a secondary market platform. The two primary platforms for pre-IPO private shares are Forge Global (forgeglobal.com) and EquityZen (equityzen.com). Both are regulated: Forge Global is a FINRA-registered broker-dealer (you can verify its status on FINRA BrokerCheck); EquityZen is an SEC-registered platform. Both facilitate transactions in shares of private companies, including OpenAI when inventory is available.
Create an account and complete accreditation verification. Both platforms require you to create an account and submit documentation confirming your accredited investor status. This typically involves providing tax returns, financial statements, or a letter from a licensed attorney, accountant, or broker-dealer. Verification may take several days.
Browse available OpenAI listings. Once verified, you can search the platform for any available OpenAI share listings. OpenAI shares may not always be in active inventory. Availability depends on whether existing OpenAI shareholders are actively selling. You may need to join a waitlist or check back regularly.
Submit a purchase interest or bid. On Forge Global, you can submit a bid at a price you are willing to pay for a specified number of shares. On EquityZen, you can express interest in a listed offering. The platform matches buyers with sellers.
Complete transaction documentation. Once a match is made, review and sign transaction documentation outlining the share class, any transfer restrictions, and the terms of the transaction. Read this carefully before signing.
Understand right of first refusal (ROFR) provisions. OpenAI may hold a right of first refusal on secondary share transfers, meaning OpenAI could exercise the right to purchase shares back at the agreed price before the transfer to you completes. ROFR provisions can delay or prevent transactions. Ask your platform representative about the current status of ROFR for OpenAI shares before committing capital.
Hold shares in a custodian account and acknowledge illiquidity. Your shares will be held in a custodian account arranged through the platform. Confirm the custody arrangement before transacting. Acknowledge in writing that these shares are illiquid and that there is no guaranteed exit.
Forge Global vs. EquityZen: A Brief Comparison
Forge Global has historically catered to institutional and high-net-worth individual investors, with minimum investments ranging from approximately $20,000 to $100,000 or more depending on the specific offering. It maintains a large inventory of pre-IPO companies and has a strong institutional reputation in the private markets space.
EquityZen has historically offered lower minimum investment thresholds, in some cases as low as $10,000, which may make it more accessible for investors at the lower end of accredited investor qualification. EquityZen's marketplace model allows investors to browse and express interest in specific offerings.
Both platforms change their minimums, fee structures, and available inventory regularly. Verify current terms directly on each platform before making any decisions. OpenAI shares may not be listed on either platform at any given time, and secondary market prices may differ significantly from the $157 billion primary round valuation.
Understanding OpenAI's Corporate Structure: What Every Investor Should Know
OpenAI's capped-profit structure had investor implications unlike anything most retail investors have encountered, and the 2025 conversion to a PBC changes those implications in ways worth understanding before you evaluate any OpenAI investment pathway.
The capped-profit model, which governed OpenAI from 2019 through the 2025 restructuring announcement, created a ceiling on what investors could earn. If you invested $1 million under the capped-profit terms and OpenAI eventually generated returns of 200 times that amount, you might collect 100 times your investment while the excess reverted to the nonprofit parent. Standard equity investments carry uncapped upside: if a company becomes worth 1,000 times your investment, you benefit proportionally. The capped-profit model eliminated that possibility and also complicated any future IPO, since most public market investors expect standard equity with no artificial ceiling.
The 2025 Public Benefit Corporation conversion removes that ceiling. A Delaware PBC is a legal corporate form, established under state statute, that codifies a public benefit mission in the company's governing documents. It does not restrict investor returns the way the capped-profit LLC did. Investors who hold equity in an OpenAI PBC hold standard equity with uncapped upside potential, subject to the normal risks of any private company investment.
One distinction is important: a PBC is not the same as a B Corp certification. B Corp is a private certification issued by the nonprofit B Lab, requiring companies to meet social and environmental performance standards. It carries no legal standing in corporate governance and is a completely different concept. OpenAI's conversion is a legal restructuring with real implications for investor return caps.
The conversion does not guarantee or confirm an IPO timeline. OpenAI could operate as a PBC indefinitely without going public. It simply removes one structural barrier that made IPO execution more complicated. The definitive signal to watch is an S-1 filing with the SEC, which would indicate that OpenAI is actively preparing for a public offering.
Risks of Investing in OpenAI (Directly or Indirectly)
Investing in OpenAI, whether directly through secondary market platforms or indirectly through MSFT, NVDA, or AI ETFs, carries several specific risks that go beyond standard market volatility.
1. Valuation Risk
As of its September 2024 funding round, OpenAI was valued at approximately $157 billion against a revenue run rate of approximately $3.4 billion, per reporting from Bloomberg and The Wall Street Journal. That implies a price-to-sales multiple of roughly 46 times 2024 revenue. Even if revenue projections of $11.6 billion for 2025 materialize, the multiple would still represent a significant premium relative to the revenue base. Buying into OpenAI exposure at these valuations means paying a price that assumes continued hypergrowth. If revenue growth slows, competition intensifies, or the broader AI investment cycle moderates, valuations could compress significantly. For a primer on reading valuation multiples in the AI sector, NVIDIA stock price analysis for beginners applies the same framework to a publicly traded AI company.
2. Illiquidity Risk
This risk applies specifically to secondary market pre-IPO shares. Once you purchase OpenAI shares on Forge Global or EquityZen, you cannot sell them on any open exchange. Your exit depends on one of three events: an OpenAI IPO, an acquisition of OpenAI by another company, or finding another willing secondary buyer. None of these outcomes is guaranteed or on any confirmed timeline. You could hold illiquid shares for years, or indefinitely, if none of these events occur.
3. Competition Risk
OpenAI operates in a market where several well-funded competitors are actively trying to displace it. Google DeepMind has the resources of Alphabet behind Gemini development. Anthropic raised billions from Amazon and Google. Meta AI is distributing Llama as open-source software, which could commoditize the foundational model layer entirely. xAI, Elon Musk's venture, is developing Grok with substantial backing. AI market leadership is not permanent, and any of these competitors could develop superior capabilities or win key enterprise contracts that shift the competitive balance.
4. Regulatory Risk
AI regulation is evolving rapidly in both the United States and the European Union. The EU AI Act came into force in 2024 and imposes compliance obligations on high-risk AI systems. In the United States, federal AI legislation remains actively debated. Regulatory requirements could increase OpenAI's compliance costs, limit certain product capabilities, or require operational changes that reduce competitive advantage.
5. Corporate Structure Risk
OpenAI's transition from capped-profit LLC to PBC involves legal complexity and is not yet fully completed as of this writing. The restructuring process could face delays, legal challenges from existing stakeholders, or complications arising from the nonprofit parent's governance rights. Until the conversion is legally finalized, uncertainty around the corporate structure persists.
6. Proxy Risk
For investors accessing OpenAI exposure through MSFT or NVDA, the correlation between those stocks and OpenAI's actual performance is imperfect. Microsoft is a $3 trillion-plus company with dozens of significant business lines. If OpenAI's valuation declines but Azure cloud growth remains strong, MSFT may continue performing well. The reverse is also true: if OpenAI performs well but Microsoft faces headwinds elsewhere, MSFT might underperform despite a positive OpenAI trajectory. Proxy investments are real exposures, but they are diluted and indirectly connected.
These risks exist alongside a genuine opportunity thesis. OpenAI's products have achieved commercial adoption at a scale few technology companies reach this quickly, its revenue trajectory is moving in the right direction, and the PBC restructuring signals corporate maturation. The risks above are factors to weigh against that thesis, not reasons to dismiss the investment case entirely.
Frequently Asked Questions About Investing in OpenAI
Is there an OpenAI stock?
No. OpenAI is a private company with no publicly traded stock as of June 2025. There is no ticker on the NYSE or NASDAQ. To gain financial exposure, your options include buying Microsoft (MSFT) as an indirect proxy, purchasing NVIDIA (NVDA) for AI infrastructure exposure, investing in AI-focused ETFs like BOTZ or AIQ, or accessing pre-IPO shares through secondary market platforms if you qualify as an accredited investor.
What is the OpenAI stock ticker symbol?
OpenAI does not have a stock ticker or stock symbol. It is a private company and its shares are not listed on any public stock exchange. If and when OpenAI completes an IPO, it would receive a ticker symbol at that time. The closest publicly traded proxy is Microsoft (NASDAQ: MSFT), which has invested approximately $13 billion in OpenAI across multiple rounds and has OpenAI technology integrated throughout its product suite via Copilot and Azure.
When will OpenAI go public?
As of June 2025, OpenAI has not announced a firm IPO date or filed an S-1 registration statement with the SEC. The company's 2025 restructuring into a Delaware Public Benefit Corporation is interpreted by many analysts as a structural step that could precede a future public offering. Watch for an SEC S-1 filing as the most reliable signal. No specific timeline has been confirmed.
Can I buy OpenAI stock on Robinhood?
No. Robinhood only lists publicly traded securities. Since OpenAI is private with no exchange listing, its shares are not available on Robinhood, Fidelity, Schwab, or any standard retail platform. Through these brokerages, you can buy publicly traded companies with AI exposure, including Microsoft (MSFT) and NVIDIA (NVDA), or AI ETFs such as BOTZ or AIQ.
What is OpenAI worth?
As of its September 2024 funding round, OpenAI was valued at approximately $157 billion, making it one of the most valuable private companies in the world, according to Bloomberg and Reuters. Private company valuations are set during funding rounds and do not fluctuate daily like public stock prices. OpenAI's revenue was estimated at $3.4 billion or more for 2024, with Wall Street Journal and Bloomberg reporting projections of $11.6 billion for 2025. These figures represent a substantial premium relative to most publicly traded technology companies at comparable revenue levels.
What stocks benefit from OpenAI?
Microsoft (MSFT) benefits most directly as OpenAI's largest investor at approximately $13 billion, with Azure and Copilot product integration creating direct revenue linkage. NVIDIA (NVDA) benefits as the primary GPU supplier for AI model training across all major AI companies. Alphabet (GOOGL) is OpenAI's primary competitor, and its AI investment across Google DeepMind and Gemini reflects the same market opportunity. AI-focused ETFs like BOTZ and AIQ hold several of these names.
Is Microsoft a good investment for OpenAI exposure?
Microsoft provides real but indirect OpenAI exposure through its approximately $13 billion investment and product integrations across Copilot and Azure AI services. OpenAI models run on Azure, and Microsoft's commercial products directly benefit from OpenAI's technology. However, Microsoft is a $3 trillion-plus diversified company where OpenAI represents one of many business lines. Buying MSFT is not a pure-play OpenAI investment. This article is informational only. Consult a qualified financial advisor before making investment decisions.
How do pre-IPO shares work?
Pre-IPO shares are equity stakes in a private company purchased before it lists on a public stock exchange. They are bought through secondary market platforms such as Forge Global or EquityZen from existing shareholders selling their vested equity. Pre-IPO shares are illiquid: you cannot sell them on any exchange, and your exit depends on an IPO, acquisition, or another secondary buyer. They require accredited investor status in the US.
How do I invest in AI stocks?
You can invest in AI stocks through any standard retail brokerage account by purchasing shares of publicly traded companies such as Microsoft (MSFT), NVIDIA (NVDA), and Alphabet (GOOGL). For diversified AI sector exposure, AI-focused ETFs such as BOTZ (Global X Robotics & Artificial Intelligence ETF) or AIQ (Global X Artificial Intelligence & Technology ETF) are accessible through the same platforms. OpenAI itself is not publicly traded and cannot be purchased directly through any retail brokerage.
What companies is OpenAI competing with?
OpenAI's primary competitors are Google DeepMind (Gemini AI models, backed by Alphabet), Anthropic (Claude AI, backed by Amazon and Google), Meta AI (Llama open-source models, backed by Meta Platforms), and xAI (Grok, founded by Elon Musk). Each competitor is well-funded and shipping competitive products across consumer and enterprise markets. The intensity of this competition is a key risk factor for investors.
Final Thoughts: Getting OpenAI Exposure in 2025
You now have a complete map of your investment options for gaining OpenAI exposure in 2025.
The four accessible pathways are: buying Microsoft (MSFT) as the most accessible publicly traded proxy with $13 billion invested and deep product integration; buying NVIDIA (NVDA) as an AI infrastructure play benefiting from all AI model training; buying AI-focused ETFs such as BOTZ, AIQ, or ARKQ for diversified sector exposure accessible to all investors; or purchasing pre-IPO shares through Forge Global or EquityZen if you qualify as an accredited investor.
Which pathway fits your situation depends on three factors. Your accredited investor status determines whether secondary market access is available to you. Your risk tolerance determines whether concentrated single-company exposure or diversified ETF coverage is more appropriate. Your investment horizon determines whether acting now through proxies makes sense or whether waiting for a direct IPO fits your plan better.
The 2025 PBC restructuring is the most significant recent development for anyone monitoring OpenAI's path toward a public offering. It removes a structural barrier that made IPO execution complicated. It does not confirm a date or a timeline. The S-1 filing, when and if it appears in the SEC EDGAR database, will be the definitive signal.
Whatever pathway you choose, consult a qualified financial advisor before committing capital. The information in this article maps your options. The decision belongs to you.
Financial Disclaimer
This article is for informational and educational purposes only and does not constitute financial, investment, legal, or tax advice. The information provided is not a recommendation to buy, sell, or hold any security. All investments involve risk, including the possible loss of principal. Past performance is not indicative of future results. Financial data and figures cited in this article were accurate as of June 2025 and may have changed since publication. Readers should verify all financial information independently. Consult a qualified financial advisor, attorney, or tax professional before making any investment decisions. The author and publisher are not responsible for any investment decisions made based on this content.
This article was written by a financial content specialist with experience covering private markets, AI sector investing, and SEC regulatory frameworks for retail investor audiences. All factual claims are sourced to named publications with dates as indicated throughout the article.
Related Reading